Hadifar S, Masoudzadeh N, Andersson B, Heydari H, Mashayekhi Goyonlo V, Kerachian M
Front Cell Infect Microbiol. 2024; 14:1416925.
PMID: 39639867
PMC: 11617529.
DOI: 10.3389/fcimb.2024.1416925.
Upadhyay S, Kumar S, Singh V, Tiwari R, Kumar A, Sundar S
Expert Rev Mol Med. 2024; 1-55.
PMID: 39587036
PMC: 11707835.
DOI: 10.1017/erm.2024.36.
Hadifar S, Masoudzadeh N, Heydari H, Mashayekhi Goyonlo V, Kerachian M, Daneshpazhooh M
Front Immunol. 2024; 15:1436029.
PMID: 39364404
PMC: 11446769.
DOI: 10.3389/fimmu.2024.1436029.
Na J, Engwerda C
Front Cell Infect Microbiol. 2024; 14:1414493.
PMID: 38881737
PMC: 11176485.
DOI: 10.3389/fcimb.2024.1414493.
Aljedaie M, Alam P
Front Genet. 2024; 14:1329339.
PMID: 38390455
PMC: 10883313.
DOI: 10.3389/fgene.2023.1329339.
Synthetic biology for combating leishmaniasis.
Khandibharad S, Singh S
Front Microbiol. 2024; 15:1338749.
PMID: 38362504
PMC: 10867266.
DOI: 10.3389/fmicb.2024.1338749.
A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection.
Naouar I, Kammoun Rebai W, Salah A, Bouguerra H, Toumi A, Hamida N
PLoS Negl Trop Dis. 2023; 17(12):e0011784.
PMID: 38064516
PMC: 10732404.
DOI: 10.1371/journal.pntd.0011784.
Is There Any Difference in the In Situ Immune Response in Active Localized Cutaneous Leishmaniasis That Respond Well or Poorly to Meglumine Antimoniate Treatment or Spontaneously Heal?.
Leite-Silva J, Oliveira-Ribeiro C, Morgado F, Pimentel M, Lyra M, Fagundes A
Microorganisms. 2023; 11(7).
PMID: 37512804
PMC: 10384164.
DOI: 10.3390/microorganisms11071631.
Field-Deployable Treatments For Leishmaniasis: Intrinsic Challenges, Recent Developments and Next Steps.
Pacheco-Fernandez T, Markle H, Verma C, Huston R, Gannavaram S, Nakhasi H
Res Rep Trop Med. 2023; 14:61-85.
PMID: 37492219
PMC: 10364832.
DOI: 10.2147/RRTM.S392606.
Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper.
De Silva P, Saad M, Thomsen H, Bano S, Ashraf S, Hasan T
J Porphyr Phthalocyanines. 2023; 24(11n12):1320-1360.
PMID: 37425217
PMC: 10327884.
DOI: 10.1142/s1088424620300098.
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis.
Yadagiri G, Singh A, Arora K, Mudavath S
Front Med (Lausanne). 2023; 10:1096458.
PMID: 37265481
PMC: 10229823.
DOI: 10.3389/fmed.2023.1096458.
Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis.
El-Dirany R, Fernandez-Rubio C, Pena-Guerrero J, Moreno E, Larrea E, Espuelas S
Pharmaceutics. 2022; 14(11).
PMID: 36432719
PMC: 9697117.
DOI: 10.3390/pharmaceutics14112528.
Immunoinformatics Studies and Design of a Potential Multi-Epitope Peptide Vaccine to Combat the Fatal Visceral Leishmaniasis.
Onile O, Musaigwa F, Ayawei N, Omoboyede V, Onile T, Oghenevovwero E
Vaccines (Basel). 2022; 10(10).
PMID: 36298463
PMC: 9610175.
DOI: 10.3390/vaccines10101598.
Mechanobiology of immune cells: Messengers, receivers and followers in leishmaniasis aiding synthetic devices.
Khandibharad S, Nimsarkar P, Singh S
Curr Res Immunol. 2022; 3:186-198.
PMID: 36051499
PMC: 9424266.
DOI: 10.1016/j.crimmu.2022.08.007.
Isolation, characterization, and functional study of extracellular vesicles derived from .
Shokouhy M, Sarvnaz H, Taslimi Y, Lajevardi M, Habibzadeh S, Mizbani A
Front Cell Infect Microbiol. 2022; 12:921410.
PMID: 35992172
PMC: 9381964.
DOI: 10.3389/fcimb.2022.921410.
MicroRNAs: master regulators in host-parasitic protist interactions.
Rojas-Pirela M, Andrade-Alviarez D, Medina L, Castillo C, Liempi A, Guerrero-Munoz J
Open Biol. 2022; 12(6):210395.
PMID: 35702995
PMC: 9198802.
DOI: 10.1098/rsob.210395.
TREM-1 Expression on the Surface of Neutrophils in Patients With Visceral Leishmaniasis Is Associated With Immunopathogenesis.
Bomfim L, Magalhaes L, Rodrigues L, Barreto A, Santos C, Dos Santos P
Front Cell Infect Microbiol. 2022; 12:863986.
PMID: 35402286
PMC: 8988227.
DOI: 10.3389/fcimb.2022.863986.
Persistent Cutaneous Infection Promotes Infection-Adapted Myelopoiesis.
Bandeira Ferreira F, Seguin O, Descoteaux A, Heinonen K
Microorganisms. 2022; 10(3).
PMID: 35336108
PMC: 8954948.
DOI: 10.3390/microorganisms10030535.
Computational System Level Approaches for Discerning Reciprocal Regulation of IL10 and IL12 in Leishmaniasis.
Khandibharad S, Singh S
Front Genet. 2022; 12:784664.
PMID: 35126456
PMC: 8807686.
DOI: 10.3389/fgene.2021.784664.
Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells.
Torres-Ruesta A, Teo T, Chan Y, Amrun S, Yeo N, Lee C
Life Sci Alliance. 2022; 5(4).
PMID: 35039441
PMC: 8807878.
DOI: 10.26508/lsa.202101272.